Pediatric Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
Department of Clinical Sciences and Community Health, Università Degli Studi Di Milano, Via Della Commenda 9, 20122, Milan, Italy.
Eur J Pediatr. 2024 Apr;183(4):1751-1758. doi: 10.1007/s00431-023-05395-1. Epub 2024 Jan 18.
Bronchiolitis is a common cause of hospitalization in infants. The long-lasting impact of hygiene and social behavior changes during the pandemic on this disease is debated. We investigated the prevalence of hospitalized cases, clinical severity, and underlying risk factors before and during pandemic. The study was conducted in 27 hospitals in Italy and included infants hospitalized for bronchiolitis during the following four periods: July 2018-March 2019, July 2020-March 2021, July 2021-March 2022, and July 2022-March 2023. Data on demographics, neonatal gestational age, breastfeeding history, underlying chronic diseases, presence of older siblings, etiologic agents, clinical course and outcome were collected. A total of 5330 patients were included in the study. Compared to 2018-19 (n = 1618), the number of hospitalizations decreased in 2020-21 (n = 121). A gradual increase was observed in 2021-22 (n = 1577) and 2022-23 (n = 2014). A higher disease severity (need and length of O-supplementation, need for non-invasive ventilation, hospital stay) occurred in the 2021-22 and, especially, the 2022-23 periods compared to 2018-19. This tendency persisted after adjusting for risk factors associated with bronchiolitis severity. Conclusions: Compared to adults, COVID-19 in infants is often asymptomatic or mildly symptomatic and rarely results in hospitalization. This study indicates that the pandemic has indirectly induced an increased burden of bronchiolitis among hospitalized infants. This shift, which is not explained by the recognized risk factors, suggests the existence of higher infant vulnerability during the last two seasons. What is known: • The pandemic led to a change in epidemiology of respiratory diseases • Large data on severity of bronchiolitis and underlying risk factors before and during COVID-19 pandemic are scarce What is new: • Compared to pre-pandemic period, hospitalizations for bronchiolitis decreased in 2020-21 and gradually increased in 2021-22 and 2022-23 • Compared to pre-pandemic period, higher disease burden occurred in 2021-22 and, especially, in 2022-23. This tendency persisted after adjusting for risk factors associated with bronchiolitis severity • The interplay among viruses, preventive measures, and the infant health deserves to be further investigated.
毛细支气管炎是婴儿住院的常见原因。大流行期间卫生和社会行为改变对这种疾病的长期影响存在争议。我们调查了大流行前后住院病例的流行率、临床严重程度和潜在的危险因素。该研究在意大利的 27 家医院进行,包括在以下四个时期因毛细支气管炎住院的婴儿:2018 年 7 月至 2019 年 3 月、2020 年 7 月至 2021 年 3 月、2021 年 7 月至 2022 年 3 月和 2022 年 7 月至 2023 年 3 月。收集了人口统计学、新生儿胎龄、母乳喂养史、潜在慢性疾病、是否有兄弟姐妹、病原体、临床过程和结局的数据。共有 5330 名患者纳入研究。与 2018-19 年(n=1618)相比,2020-21 年(n=121)住院人数减少。2021-22 年(n=1577)和 2022-23 年(n=2014)观察到逐渐增加。与 2018-19 年相比,2021-22 年(需要和补充氧气的时间、需要无创通气、住院时间)和 2022-23 年(需要和补充氧气的时间、需要无创通气、住院时间)疾病严重程度更高。在调整与毛细支气管炎严重程度相关的危险因素后,这种趋势仍然存在。结论:与成人相比,婴儿 COVID-19 通常无症状或症状轻微,很少导致住院。本研究表明,大流行间接导致住院婴儿毛细支气管炎负担增加。这种变化不能用已知的危险因素来解释,这表明在过去两个季节婴儿的脆弱性更高。已知:• 大流行导致呼吸道疾病的流行病学发生变化• COVID-19 大流行前后关于毛细支气管炎严重程度和潜在危险因素的大量数据稀缺新内容:• 与大流行前相比,2020-21 年因毛细支气管炎住院的人数减少,2021-22 年和 2022-23 年逐渐增加• 与大流行前相比,2021-22 年疾病负担更高,尤其是 2022-23 年。在调整与毛细支气管炎严重程度相关的危险因素后,这种趋势仍然存在• 病毒、预防措施和婴儿健康之间的相互作用值得进一步研究。